Alembic Pharmaceuticals gets USFDA nod for Levothyroxine Sodium Tablets, used as replacement therapy for congenital or acquired hypothyroidism and are also indicated as an adjunct treatment in certain thyroid cancer cases. This boosts Alembic Pharma’s ANDA tally to 239.
